Tilray (TLRY) Sets New 1-Year High at $108.27
Tilray Inc (NASDAQ:TLRY)’s share price hit a new 52-week high on Wednesday . The company traded as high as $108.27 and last traded at $100.50, with a volume of 267295 shares changing hands. The stock had previously closed at $103.30.
A number of equities analysts have recently weighed in on TLRY shares. Cowen started coverage on Tilray in a report on Monday, August 13th. They issued an “outperform” rating and a $34.00 target price on the stock. Roth Capital started coverage on Tilray in a report on Tuesday, August 14th. They issued a “buy” rating and a $35.00 target price on the stock. Finally, Northland Securities downgraded Tilray from an “outperform” rating to a “market perform” rating in a report on Thursday, September 6th.
Tilray (NASDAQ:TLRY) last issued its earnings results on Tuesday, August 28th. The company reported ($0.17) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.09) by ($0.08). The firm had revenue of $9.70 million during the quarter, compared to the consensus estimate of $9.01 million. The business’s quarterly revenue was up 94.0% on a year-over-year basis. sell-side analysts anticipate that Tilray Inc will post -0.45 earnings per share for the current fiscal year.
Tilray Company Profile (NASDAQ:TLRY)
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc was incorporated in 2018 and is headquartered in Nanaimo, Canada.
Featured Article: Find a Trading Strategy That Works
Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.